Simcere Zaiming Announce Approval of Cetuximab Beta in China by the NMPA ...Middle East

PR Newswire - News
NANJING, China, June 26, 2024 /PRNewswire/ -- On June 25, 2024, Simcere Zaiming, an innovative oncology company and a subsidiary of Simcere Pharmaceutical Group (2096.HK), announced that Enlituo® (generic name: cetuximab beta injection), a new generation anti-epidermal growth factor...

Hence then, the article about simcere zaiming announce approval of cetuximab beta in china by the nmpa was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Simcere Zaiming Announce Approval of Cetuximab Beta in China by the NMPA )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News